Impax Laboratories (IPXL)

18.42 -0.22  -1.18%  May 17, 8:00PM
Add to Watchlists Create an Alert

Impax Laboratories Cash from Operations Quarterly:

57.75M for March 31, 2013
View Full Chart

Impax Laboratories Cash from Operations Quarterly Chart

    Impax Laboratories Historical Cash from Operations Quarterly Data

    Pro Data Export
    Dates:  to
    Viewing 1 of 1   First  Previous First    Next  Last   Last

    There is no data for the selected date range.

    Data for this Date Range  
    March 31, 2013 57.75M
    Dec. 31, 2012 -41.08M
    Sept. 30, 2012 67.96M
    June 30, 2012 55.60M
    March 31, 2012 23.73M
    Dec. 31, 2011 -4.096M
    Sept. 30, 2011 25.70M
    June 30, 2011 -16.25M
    March 31, 2011 1.011M
    Dec. 31, 2010 -10.12M
    Sept. 30, 2010 31.77M
    June 30, 2010 190.50M
    March 31, 2010 37.61M
    Dec. 31, 2009 -5.79M
    Sept. 30, 2009 -0.308M
    June 30, 2009 16.02M
    March 31, 2009 -18.08M
    Dec. 31, 2008 44.08M
    Sept. 30, 2008 -6.934M
    June 30, 2008 31.34M
       
    March 31, 2008 Go Pro
    Sept. 30, 2004 Go Pro
    June 30, 2004 Go Pro
    March 31, 2004 Go Pro
    Dec. 31, 2003 Go Pro
    Sept. 30, 2003 Go Pro
    June 30, 2003 Go Pro
    March 31, 2003 Go Pro
    Dec. 31, 2002 Go Pro
    Sept. 30, 2002 Go Pro
    June 30, 2002 Go Pro
    March 31, 2002 Go Pro
    Dec. 31, 2001 Go Pro
    Sept. 30, 2001 Go Pro
    June 30, 2001 Go Pro
    March 31, 2001 Go Pro
    Dec. 31, 2000 Go Pro
    Sept. 30, 2000 Go Pro
    June 30, 2000 Go Pro
    March 31, 2000 Go Pro

    About Cash From Operations

    An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.

    Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
    Learn More

    Get data for

    IPXL Cash from Operations Quarterly Benchmarks

    Companies
    Endo Health Solutions -58.75M
    Actavis 218.60M
    Teva Pharmaceutical Industries 1.102B

    IPXL Cash from Operations Quarterly Rankings

    Overall 87th percentile
    978 of 7590
    Sector 89th percentile
    67 of 651 in Healthcare
    Industry 86th percentile
    9 of 65 in Drug Manufacturers - Specialty & Generic

    IPXL Cash from Operations Quarterly Range, Past 5 Years

    Minimum -41.08M Dec 2012
    Maximum 190.50M Jun 2010
    Average 24.02M